Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF

Healthcare Biotechnology


GREY:IPHAF - Post by User

Isotechnika Pharma Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by Plato5on Apr 11, 2010 12:20pm
972 Views
Post# 16979337

Reuters Notices ISA and voclosporin

Reuters Notices ISA and voclosporin"Canadian investors may want to take anotherlook at biotech stocks in coming months, when three homegrown companies will see treatments go before U.S. or Europeanregulators for approval for commercial production."

https://www.reuters.com/article/idUSN0922011820100411
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities